With revenue and earnings plummeting more than 30% year over year why does nobody seem to be concerned? Celebrex goes off patent THIS YEAR and the fiddler plays as Rome burns.
Fair enough. But you are pinning a 20 million dollar price on a company composed of a guy sitting on his couch with a laptop on his lap. If this stock was 0.06 it would still be grotesquely over valued by any possible measure.
The link to the company web site takes you too a penny bidding site and is not related to what is described in the profile at all. The contact list is the phone number of the CEO of the company. There is not a single indication that there is any assets at all. It is a complete scam and anyone with a functioning brain can see that.
BDC's are a better idea from a diversification stand point as well. FSC funds a wide variety of sectors.
That is an interesting strategy. FSC has been a colossal cash machine for me. It is like free money.
The stock WAS at $10.10 before the issue. Then investors that are clueless about how BDC's work saw the news story and sold the stock. In other words, but the dip. If you have been wanting to add, do it now.
You must be new to PACB then. Volatility is always high and a 10% run up or down is par for the course. The massive short interest is partly to blame. I bought at $2.90, held it up to $8, rode it back down to $4 and now it is in the middle. That won't end any time soon as the shorts love to smash this stock.
You can't. The stock will gap up at open and trade about $50. Maybe if you wait a quarter or 2 you can get in at a real price.
The difference also being that PACB is available NOW while the Genia system (as well as the Oxford nanopore technology) is still just vaporware. Meaning it is still in the imagination stages. You cannot buy and use a genia system today.
Why would Roche buy PACB when they already have an iron clad deal in writing with them giving them exclusive rights to PACB technology for cancer diagnostics applications, and they paid peanuts for it?